Remove Aging and mental health Remove Definition Remove Pharmaceuticals
article thumbnail

In Brain Chemistry We Trust—The Gospel According to Pharma

Mad in America

Depression was sold to us as a simple problem of serotonin insufficiency, a convenient narrative that made drug companies like Eli Lilly, Forest Pharmaceuticals, and Pfizer very rich. As a former pharmaceutical advertising writer, I not only witnessed the explosive growth in antidepressant drugs, I contributed to it.

article thumbnail

Behind the Smiles: Mental Health in South Korea’s High-Pressure Society

Mad in America

A Silent Crisis Despite rising awareness, mental health is still a taboo topic in many Korean families. of Koreans reported experiencing at least one mental health issue in the past year, such as chronic stress, anxiety, or depressive symptoms. Ive also been one of them. Psychotherapy is rarely suggested.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Mad in America

As such, the scandal now serves as a historical verdict on the ethics of American psychiatry, and by extension, the National Institute of Mental Health (NIMH). “The esteem held by our field in the age of modern medicine rests on the validity of our scientific pursuits.

article thumbnail

Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction

Mad in America

You’re also an author, and you’ve written on topics such as aging, genetics, mental representation, biological functions, mechanisms in science, and the concept of information in neuroscience. So why do we call schizophrenia a mental disorder, but not believing in conspiracy theories?

article thumbnail

The Maudsley Deprescribing Guidelines: An Interview with David Taylor and Mark Horowitz

Mad in America

Beyond academia, he contributes significantly to public health policy as a member of the United Kingdom’s Department of Transport expert panel that introduced drug-driving regulations. Mark Horowitz is a clinical research fellow in psychiatry at the National Health Service (NHS) in London. We thought we’d write it.

article thumbnail

Exploding Myths About Schizophrenia: An Interview with Courtenay Harding

Mad in America

The recipient of many honors, she received the Alexander Gralnick Research Investigator Award from the American Psychological Foundation for “exceptional contributions to the study of schizophrenia and other serious mental illnesses and for mentoring a new generation of researchers.” They were definitely not ready to leave.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.